Zika vaccines and immunogenic compositions, and methods of using the same
Abstract:
The present disclosure relates to Zika virus vaccines and immunogenic compositions having one or more antigens from a Zika virus (e.g., a Zika virus clonal isolate, a non-human cell adapted Zika virus, etc.), and methods of manufacture, formulation, testing, and uses thereof.
Information query
Patent Agency Ranking
0/0